Postmenopausal hormone replacement therapy, lipoprotein metabolism, and coronary heart disease

Journal of Cardiovascular Pharmacology

Volumn 28, Issue SUPPL. 5, 1996, Pages

  Crook, D ^a   Birkhauser, ^a  

^a Wynn Institute   (United Kingdom)

Author keywords

Coronary heart disease; High density lipoprotein; Hormone replacement therapy; Lipoproteins; Low density lipoprotein; Risk

Indexed keywords

CHOLESTEROL; CONJUGATED ESTROGEN; DYDROGESTERONE; ESTROGEN; GESTAGEN; HIGH DENSITY LIPOPROTEIN; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN; MEDROGESTONE; MEDROXYPROGESTERONE ACETATE; PROGESTERONE; TIBOLONE; TRIACYLGLYCEROL;

CLINICAL TRIAL; CONFERENCE PAPER; ESTROGEN THERAPY; HEART PROTECTION; HORMONE SUBSTITUTION; HUMAN; ISCHEMIC HEART DISEASE; LIPID OXIDATION; LIPOPROTEIN METABOLISM; ORAL DRUG ADMINISTRATION; POSTMENOPAUSE; PRIORITY JOURNAL; TRANSDERMAL DRUG ADMINISTRATION;

EID: 0029908063     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (0)